Shi-Ping Chen

Shi-Ping Chen

Auto-generated profile, based on publicly available information

Shi-Ping Chen

BGI Genomics, BGI-Shenzhen, Shenzhen, China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 January 2026 in BMC Public Health
Verified
Journal Article
Open access
PDF file
TJTing Jiang
Ting Jiang
SCShi-Ping Chen
Shi-Ping Chen
MZMiao-Miao Zhao
Miao-Miao Zhao
XHXiao-Yan Huang
Xiao-Yan Huang
YJYin-Hua Jiang
Yin-Hua Jiang
GQGang Qin
Gang Qin
Thalassemia is a significant public health issue in many high-prevalence countries. Despite progress in thalassemia management, limited public awareness an

24 June 2019 in bioRxiv
Verified
Preprint
Open access
PDF file
ZYZhen-Zhen Yin
Zhen-Zhen Yin
SQShoufang Qu
Shoufang Qu
CHChuan-Feng Huang
Chuan-Feng Huang
FCFang Chen
Fang Chen
JLJian-Biao Li
Jian-Biao Li
JHJie Huang
Jie Huang
Thalassemia is one of the most common autosomal recessive inherited diseases worldwide, and it is also highly prevalent and variable in Southern China. Various types of genetic testing technologies have been developed for diagnosis and screening of thalassemia. Characterized genomic DNA reference materials are necessary for assay development, validation, proficiency testing and quality assurance. However, there is no publicly available reference materials for thalassemia genetic testing as yet. To address the need for these materials, the National Institutes for Food and Drug Control and the China National Gene Bank established 31 new cell lines with 2 wild genotypes and 29 distinct genotypes of thalassemia which account for approximately 90% thalassemia carriers in China. The genomic DNA of 31 cell lines were characterized by four clinical genetic testing laboratories using different genetic testing methods and technology platforms. The genotyping results were concordant among four laboratories. In addition, the results of stability test demonstrated that the genotypes of these DNA samples were not influenced by preanalytical conditions such as long-term exposure to high temperature(37oC) environment and repeated freeze-thawing. In conclusion, we developed the first national panel of 31 genomic DNA reference materials which are renewable and publicly available for the quality assurance of various genetic testing methods and will facilitate research and development in thalassemia genetic testing.